UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

Annals of oncology, 2008-08, Vol.19 (8), p.1477-1484

2008

Volltextzugriff (PDF)

Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma

Annals of oncology, 2009-05, Vol.20 (5), p.955-960

2009

Volltextzugriff (PDF)

Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases

Annals of oncology, 2010-06, Vol.21 (6), p.1383-1385

2010

Volltextzugriff (PDF)

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

Annals of oncology, 2018-01, Vol.29 (1), p.256-263

2018

Volltextzugriff (PDF)

Synergistic anti-cancer activity of tyrosine kinase inhibitors and paclitaxel with radiation on anaplastic thyroid cancer in vitro and in vivo

Annals of oncology, 2018-10, Vol.29, p.viii645-viii645

2018

Volltextzugriff (PDF)

Synergistic anti-cancer effect of histone deacetylase inhibition and blockade of the glycolytic pathway

Annals of oncology, 2018-10, Vol.29, p.viii646-viii646

2018

Volltextzugriff (PDF)

Prevalence, risk factors and management of opioid-induced constipation in cancer pain: A nationwide, cross-sectional study in Korea

Annals of oncology, 2018-10, Vol.29, p.viii636-viii636

2018

Volltextzugriff (PDF)

Role of HSP27 in trastuzumab resistance in HER2-overexpressing breast cancer

Annals of oncology, 2017-11, Vol.28, p.x24-x24

2017

Volltextzugriff (PDF)

Treatment outcomes after post-operative radiotherapy in triple-negative breast cancer: Multi-institutional retrospective study (KROG 17-05)

Annals of oncology, 2019-05, Vol.30, p.iii40-iii40

2019

Volltextzugriff (PDF)

A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer

Annals of oncology, 2015-06, Vol.26 (6), p.1142-1148

2015

Volltextzugriff (PDF)

The need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29, p.viii512-viii512

2018

Volltextzugriff (PDF)

Real world data of osimertinib in patients with central nervous system (CNS) metastasis in ASTRIS Korean subset

Annals of oncology, 2018-10, Vol.29, p.viii522-viii522

2018

Volltextzugriff (PDF)

A real-world study of osimertinib: ASTRIS 2nd DCO Korean subgroup analysis

Annals of oncology, 2018-11, Vol.29, p.ix160-ix160

2018

Volltextzugriff (PDF)

Reply to the letter to the editor ‘KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC’ by Robles et al

Annals of oncology, 2016-02, Vol.27 (2), p.361-363

2016

Volltextzugriff (PDF)

1823PSynergistic anti-cancer effect of histone deacetylase inhibition and blockade of the glycolytic pathway

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1820PDSynergistic anti-cancer activity of tyrosine kinase inhibitors and paclitaxel with radiation on anaplastic thyroid cancer in vitro and in vivo

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1794PPrevalence, risk factors and management of opioid-induced constipation in cancer pain: A nationwide, cross-sectional study in Korea

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1724P Secreted kinase FAM20C promotes stromal remodeling via inflammatory cancer-associated fibroblast activation in pancreatic cancer microenvironment

Annals of oncology, 2022-09, Vol.33, p.S1326

2022

Volltextzugriff (PDF)

A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore

Annals of oncology, 2020-07, Vol.31 (7), p.840-843

2020

Volltextzugriff (PDF)

1365TiP A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy

Annals of oncology, 2021-09, Vol.32, p.S1035-S1035

2021

Volltextzugriff (PDF)

1539PA phase II open-label, multicentre study to assess the anti-tumour activity of afatinib in patients with activating epidermal growth factor receptor mutation (EGFRm) from circulating tumour DNA (CtDNA)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Modulation of specificity protein 1 (SP1) is a novel therapeutic strategy for pancreatic cancer

Annals of oncology, 2016-10, Vol.27, p.vi40-vi40

2016

Volltextzugriff (PDF)

127PTreatment outcomes after post-operative radiotherapy in triple-negative breast cancer: Multi-institutional retrospective study (KROG 17-05)

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

1418PThe need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

The resistance mechanism of FGFR2 amplified gastric cancer cells against AZD4547, a fibroblast growth factor receptor inhibitor

Annals of oncology, 2016-10, Vol.27, p.vi7-vi7

2016

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(231)

Publikationsform

Artikel
(231)

Sprache

Englisch
(231)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(64)
Life Sciences & Biomedicine
(61)
Oncology
(61)
Science & Technology
(61)
Female
(54)
Middle Aged
(52)
Aged
(47)
Biological And Medical Sciences
(46)
Male
(46)
Medical Sciences
(46)
Antineoplastic Agents
(45)
Pharmacology. Drug Treatments
(45)
Adult
(43)
Prognosis
(24)
Treatment Outcome
(24)
Tumors
(24)
Aged, 80 And Over
(23)
Neoplasm Staging
(22)
Disease-Free Survival
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(231)
Ovid SocietyJournals and Single Titles
(231)
MEDLINE
(64)
IngentaConnect Journals
(15)

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma

Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

Synergistic anti-cancer activity of tyrosine kinase inhibitors and paclitaxel with radiation on anaplastic thyroid cancer in vitro and in vivo

Synergistic anti-cancer effect of histone deacetylase inhibition and blockade of the glycolytic pathway

Prevalence, risk factors and management of opioid-induced constipation in cancer pain: A nationwide, cross-sectional study in Korea

Role of HSP27 in trastuzumab resistance in HER2-overexpressing breast cancer

Treatment outcomes after post-operative radiotherapy in triple-negative breast cancer: Multi-institutional retrospective study (KROG 17-05)

A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer

The need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer

Real world data of osimertinib in patients with central nervous system (CNS) metastasis in ASTRIS Korean subset

A real-world study of osimertinib: ASTRIS 2nd DCO Korean subgroup analysis

Reply to the letter to the editor ‘KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC’ by Robles et al

1823PSynergistic anti-cancer effect of histone deacetylase inhibition and blockade of the glycolytic pathway

1820PDSynergistic anti-cancer activity of tyrosine kinase inhibitors and paclitaxel with radiation on anaplastic thyroid cancer in vitro and in vivo

1794PPrevalence, risk factors and management of opioid-induced constipation in cancer pain: A nationwide, cross-sectional study in Korea

1724P Secreted kinase FAM20C promotes stromal remodeling via inflammatory cancer-associated fibroblast activation in pancreatic cancer microenvironment

A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore

1365TiP A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy

1539PA phase II open-label, multicentre study to assess the anti-tumour activity of afatinib in patients with activating epidermal growth factor receptor mutation (EGFRm) from circulating tumour DNA (CtDNA)

Modulation of specificity protein 1 (SP1) is a novel therapeutic strategy for pancreatic cancer

127PTreatment outcomes after post-operative radiotherapy in triple-negative breast cancer: Multi-institutional retrospective study (KROG 17-05)

1418PThe need of re-biopsy: Increase in PD-L1 expression from initial stage to recurrence of non-small cell lung cancer

The resistance mechanism of FGFR2 amplified gastric cancer cells against AZD4547, a fibroblast growth factor receptor inhibitor

Aktive Filter

Suchergebnisse filtern